The genetic events associated with the development and progression of head and neck squamous carcinoma (HNSC) are largely unknown. We analysed 12 matched pairs of histologically normal squamous mucosa and tumor specimens from six conventional and six phenotypic variants HNSC to define the differentially expressed genes in these tumors. Parallel expression analysis of 8055 unique genes was performed, and the level of the hybridization signal for each gene was measured after normalization. Hierarchical cluster analysis of the expressed genes showed distinct interand intra-tumoral patterns in and between conventional squamous carcinoma and squamous carcinoma variants. We also identified 26 (0.32%) differentially expressed genes that were consistently different between matched pairs of normal and tumor specimens; a selected set of the overexpressed genes was validated using real-time quantitative RT -PCR. The majority of the genes were associated with differentiation and proliferation. Our study defines a set of genes that could form the basis for the construction of limited HNSC targeted expression array and indepth studies and further highlights gene profile differences that may be useful in pathobiologic classification of HNSC.
Introduction
Head and neck squamous carcinoma (HNSC) is the fifth most common cancer in the United States with an estimated 40 000 annual new cases (Greenlee et al., 2000) and a mortality rate of approximately 50% (Parkin et al., 1999) . These tumors encompass a spectrum of phenotypic entities and variable biological behaviors within the currently used TNM staging system (Helliwell, 2001) . The majority of HNSCs, represents the conventional keratinizing variant; less common are the verrucous, papillary, basaloid and the sarcomatoid subtypes. While the poorly differentiated grade of the conventional, the basaloid and the sarcomatoid subtypes are considered highly malignant, the verrucous, papillary and the well-differentiated grade of the conventional types are generally less aggressive (Banks et al., 1992; Ellis et al., 1987; Medina et al., 1984; Suarez et al., 2000; Wain et al., 1986) .
Despite advances in the diagnosis, management, and molecular understanding of HNSC, minimal improvement in patient survival and quality of life has been achieved (Califano et al., 1996; El-Naggar et al., 1995 Lai et al., 1995; Vokes et al., 1993) . Factors that impede progress in this field are late detection, phenotypic heterogeneity, and the lack of surrogate biomarkers for better stratification of individual patients. Large-scale gene-expression profiling of experimental and primary tumors have recently been tested for the identification and understanding of the biological function of genes involved in critical pathways associated with tumorigenesis (Diehn et al., 2000; Pollack et al., 1999; Zhang et al., 1997) .
Studies of different human cancer subtypes using cDNA microarray analysis have led to novel classification and biological profiling of certain tumors (Anbazhagan et al., 1999; Chaib et al., 2001; Huang et al., 2000; Ono et al., 2000; Petersen et al., 2000; Sallinen et al., 2000; Sgroi et al., 1999; Shim et al., 1998; Wang et al., 2000) . Similar studies of head and neck cancer have been limited in tumor type and number and used different array platforms (Alevizos et al., 2001; Leethanakul et al., 2000; Villaret et al., 2000) . None of the studies addressed the global genomic expression profiles in the different phenotypic variants of squamous carcinoma.
To identify the differentially expressed genes associated with HNSC and to investigate their role in the classification of HNSCs, we analysed total RNA extracted from 12 matched, macrodissected, histologically normal squamous mucosa and carcinoma specimens using a membrane-based gene-expression array platform.
Results
Clinicopathologic and patient characteristics are summarized in Table 1 . The 12 tumors were composed of six conventional squamous cell carcinoma (SCC) and six SCC variants. The expression levels of specific genes were determined by densitometric scanning of hybridized signals. Comparative analysis of hybridized blots of normal and tumor tissues revealed several genes that were differentially expressed in several patients.
Figure 1 presents scatter plots of logarithm-10, transformed gene-expression intensity for tumor versus normal tissue in the first experiment of tissue from patient 2. Figure 1 shows that the raw gene expression data had higher intensity in the normal versus tumor tissue before normalization (left panel); after normalization, the loess line was shifted to the 458 line as intended (right panel). Most of the housekeeping genes (in orange) were also distributed along the 458 line. Selected genes are marked in circles and printed with the Genebank accession number. Table 2 presents the ratio of highly expressed genes in each HNSC patient. Only consistently differentially expressed genes identified by at least three of the five methods defined in the Statistical Considerations section were selected. Using those criteria, we identified 26 distinct genes with significantly different expression between matched pairs of tumor and normal squamous mucosa tissue. For membrane GF200, seven genes were highly expressed in tumor tissue (in bold), and none were highly expressed in normal tissue from conventional SCC patients. On the other hand, eight genes were highly expressed in normal tissue (in italic), and none were highly expressed in tumor tissue from patients with variant SCC. For membrane 211, six genes were highly expressed in tumor tissue and one gene was highly expressed in normal tissue from patient with conventional SCC. Finally, 10 genes were highly expressed in normal tissues, while none were highly expressed in tumor tissue from patients with variant SCC. This could possibly be attributed to expression heterogeneity between conventional squamous carcinoma and their variants. Four genes (corniffin, S100A2 gene, Keratin 5, and CYSTATIN B) showed consistent differential expression in both GF200 and GF211 membranes. Calgranulin A and CYSTATIN A were highly expressed in tumor tissue from patients with conventional SCC but were highly expressed in normal tissue from patients with variant SCC.
Genes that were highly expressed in most tumors included keratin-5, small proline-rich protein 1B (cornifin), S100A2, small nuclear riboprotein SMD1 (SNRP), human mRNA for calgizzarin, interferon alpha, keratin-14, S-100 calcium-binding protein A8, fatty acid-binding protein-epidermal, and CYSTATIN A. To verify the level of expression for some of the genes identified by array analysis, we performed realtime QT -RT -PCR analysis on tissue from patient 2 for keratin-5 and SNRP genes on four tumors with different levels of expression (Figure 2a,b) . QT -RT -PCR confirmed the status of the expression of these genes, which had been revealed by the array method. We observed, however, that in high-expression tumors, real-time QT -RT -PCR gave higher values than array analysis. Table 3 provides summary statistics for the differentially expressed genes for each of the five statistical methods applied. Highly expressed genes that met the cutoff value are shown in bold (see footnote, Table 3 ). For example, in GF200 for conventional SCC patients, the average expression of cornifin in tumor tissue was 9.06 fold higher than in normal tissue (Method 1). The average ranking was 1.7 (1 being the highest, Method 2). It had at least a twofold higher expression in tumor tissue than in (Method 3) , and the gene ranked in the top one-percentile in all six patients (Method 4). The t-statistic was 8.85, which was much higher than 3.365, the 99th percentile of a tdistribution with five degrees of freedom. The differential expression was clearly evident in the cornifin example, which showed consistently high expression in tumor tissue by five of the five methods. Bold numbers are high in tumor; italic numbers are high in normal Similarly, small nuclear ribonucleoprotein and calgizzarin were also selected by all five methods as being highly expressed. However, S100A2, keratin 5, and fatty acid-binding protein were selected by four of the five methods in GF200. In GF211 membrane, for patients with conventional SCC, cornifin and S100A2 were also selected by all five methods, and keratins 5 and 14, S100 calcium-binding protein A8, and CYSTATIN A were selected by four of the five methods. Although myosin was the only gene identified as being highly expressed in normal tissue from patients with conventional SCC, the evidence is not very strong because the mean expression was just 1.98-fold higher in normal tissue and the t-statistic was 2.50 and was highly expressed in normal tissue in only three of the six patients by the twofold and top onepercentile criteria. From the patients with variant SCC, eight genes were selected as being highly expressed in normal tissue by GF200. However, none of them were statistically significant at the 1% level by t-test (method 5). Ten genes were selected as being highly expressed in normal tissue by GF211; only CYSTATIN-A met all five criteria. None of the genes showed a consistently high expression in normal tissue in all six patients. As presented earlier, the evidence of highly expressed genes in normal tissue was not as strong as the evidence of highly expressed genes in tumor tissue. The data based on combined t-statistics and simple averages for the six patients with conventional SCC using GF200 is plotted in Figure 3 . Four reference lines of twofold expression in T/N or N/T ratios and 99th percentiles of the t-distribution with five degrees of freedom (+3.365 on the y-coordinate) and the Genebank accession number were added next to the selected genes to facilitate interpretation.
Most of the genes are located in the center of Figure  3 in which no differential expression between normal and tumor tissue pairs was found. The upper-left corner contains genes that had high expression in tumor specimens by both the simple-average method and the t-test method. Only three genes (cornifin, small nuclear ribonucleoprotein SMD1, and calgizzarin) were identified in this category. Two other genes (keratin 5 and human mRNA for fatty acid binding proteinepidermal) had higher than twofold expression in tumor tissue by simple average, but the t-statistics showed expression slightly below the cut-off level.
There were approximately 30 genes each with tstatistics greater or lower than 3.365, but the average mean difference was within twofold. This is illustrated by the human hematopoietic progenitor kinase gene (Acc no.=T50313), in which the t-statistic was 720.19 but the mean differential expression ratio between tumor and normal tissue was only 0.96. Further examination of the data showed that this gene had The cutoff values used for selecting differentially expressed genes by each of the five methods are: Method 1: twofold expression. Method 2: the top one percentile of the average ranking, which are for conventional SCC: 957.4 and 924.2 for high in tumour in GF200 and GF211; and 955.8 for high in normal in GF211. For variant SCC: 182./5 and 925.1 for high in normal in GF200 and GF211, respectively. Method 3: 3, Method 4: 3, Method 5: 3.365
only slightly higher expression in normal tissues but it was consistent in all six patients. The small standard deviation contributed to the extreme t-statistic. These results underscore that more than one criterion is needed for a reliable selection of genes. Hierarchical clustering of gene expression of membrane GF200 is presented in Figure 4a ,b; genes with high expression in tumor tissue are shown in red, and those with high expression in normal tissue are shown in green. A total of 224 differentially expressed genes in patients with either conventional SCC or variant SCC were selected for cluster analysis. These genes were among the top 100 genes on the differentially expressed list in either tumor or normal tissue as identified by at least two of the three methods (average expression, common expression, and t-test methods). This clustering placed conventional SCC together (R02 -R07) and separate from all histologic variants of SCC (R08 -R13). Interestingly, all five tongue tumors (R02 -R05, R07) within the conventional cases were grouped close to each other but were distant from the only conventional SCC from the gingiva (R06) (Figure 4a ). Within the histologic variants, sarcomatoid (R11, R12) and verrucous (R08, R10) carcinomas clustered close to one another while the basaloid and papillary variants were separate but close to the sarcomatoid carcinomas. In region 1, these genes include spleen tyrosine kinase, calgizzarin, keratin 5, small nuclear ribonucleoprotein SMD1, cornifin, keratin 19, small nuclear RNA-activating complex and human small proline-rich protein (sprll), and gap junction protein, beta 2. We also noticed that in tumor tissue from patient 11, unlike other specimens from variant SCC cases, had high expression of some of these genes. In the selected region 2, we also identified several interesting genes that had high expression in tumor tissue for conventional SCC but were low in expression in tumor tissue from variant SCC patients. These included retinoid acid-inducible end, ESTs highly similar to RAS, fatty acid-binding protein-epidermal, human G0S3 mRNA, ESTs highly similar to cytochrome P450, CYSTATIN B, Mal T-cell differentiation protein, kallmann syndrome 1 sequence, keratin 13, annexin 1, and p53BP1 p53-binding protein. Figure 4b illustrates a selected segment that highlights gene clusters that were differentially expressed in conventional SCC of patient no. 7. In this young female patient with advanced stage disease and moderately differentiated squamous carcinomas numerous EST-and known genes were reduced in the tumor. These genes included activating kinase-1, epidermal growth factor receptor, matrix metalloproteinase-7 and c-myc bindings protein genes (data not shown).
Similarly, 222 differentially expressed genes were selected from GF211 to be included in the cluster analysis (Figure 5a) . We found that genes were clustered together in patients with conventional SCC, except in the case of patient 5; the genes from this patient were mixed with genes from variant SCC patients. For variant SCC patients 8 and 10 (verrucuous carcinoma) and patients 11 and 12 (sarcomatoid carcinoma) their genes were clustered together as seen in GF200. The remaining three patients (patient 5 with conventional SCC, patient 13 with papillary carcinoma, and patient 9 with basaloid squamous carcinoma) were closer to sarcomatoid carcinoma than verrucous carcinoma.
A more detailed look at two selected regions ( Figure  5b ) shows that in region 1, genes including S100A2, cornifin, sprll, annexin VIII, S100 calcium-binding protein A8, envoplakin, gap junction protein and keratin 5 tended to have consistently high expression in tumor tissue for conventional SCC. Region 2 contains genes such as CYSTATIN A, keratin 13, keratin 4, CYSTA-TIN B, annexin 1, transglutaminase 3, and Mal T-cell differentiation protein, which all had high expression in normal tissue in variant SCC. Immunohistochemical evaluation of keratins 5 and 15 showed moderate immunostaining for both in tumors from patients no 2, 3, 6 and 7 with conventional SCC (Figure 6a,b) and negative staining in tumors from patients no 8, 9, 12 and 13 with variant squamous carcinoma.
Discussion
cDNA expression array analysis is a powerful technique for large-scale comparative analysis of differentially expressed genes in experimental and primary tumor investigations (Amundson et al., 1999; Emmert-Buck et al., 2000; Zhang et al., 1997) . This approach, in contrast to DNA-based sequence platforms, provides valuable information on the functional status of genes under both physiological and pathological conditions (DeBenedetti et al., 2000; EmmertBuck et al., 2000) . Defined objectives, optimal experimental conditions and robust statistical support are prerequisites for successful array analysis due to the variable technical factors and the magnitude of data generated. In this study, we interrogated gene expres- Figure 3 Example of comparative data analysis using t-statistic and the mean of the gene expression for conventional HNSC for patients using GF200 sion in 12 matched sets of histologically normal squamous mucosa and tumor specimens from patients with conventional and variant HNSC to determine the effect of gene expression on the classification and potential biological assessment of HNSC.
We identified 26 (0.32%) of 8055 genes to be differentially expressed in normal and tumor samples and these represented various differentiation and cell cycle associated genes. The low number reported here can be attributed to the stringent criteria applied for the identification of these genes. Using relatively relaxed analysis (e.g twofolds, top 5% average, three common twofolds, three common 5% and t-test=0.05)
showed widely variable levels of expression between tumors of the extra-genes identified, suggesting inconsistent association with squamous tumorigenesis. These genes, however, may play a role in individual tumor biology and may be included in future construction of customized head and neck array. A recent study of HNSC using 985 microarrayed genes selected from a subtractive library of these tumors and squamous mucosa only identified nine genes to be differentially expressed between tumor and normal samples (Villaret et al., 2000) . Our results and those of others underscore the limited scope of differentially expressed genes associated with tumorigenesis (Bertucci et Sgroi et al., 1999; Wang et al., 2000) . Only one study using a similar nylon membrane platform has been published but the number of shared genes between our and their study was limited (Leethanakul et al., 2000) . These authors reported a pattern of decreased differentiation-associated cytokeratins and overexpression of signal transduction, proliferation and angiogenesis-related genes. Contrary to that study, we and others (Villaret et al., 2000) observed elevation of certain keratins, especially in the conventional HNSC specimens. The differences between our studies could be attributed to variations in the genes arrayed on the membranes from different sources.
In our study, we show a unique difference in the overall pattern of expression and of certain keratins between conventional and variant HNSC specimens. In general, all differentially elevated genes were found in conventional squamous tumors while squamous carcinoma variants showed lower expression. The reason for such collective differences are currently unknown and may be related to an early switch in the expression of these and possibly other events in the phenotypic diversion of squamous tumorigenesis. Conventional SCC manifested striking elevation in keratins 5 and 14, while none of the variants, including verrucous carcinoma, showed changes in those genes. Both of the keratins are expressed in basal cells and may reflect a hyperproliferative state in carcinomas, as previously shown in the basal and suprabasal cell layers of well and poorly differentiated squamous carcinomas (Hesse et al., 2001) . Interestingly, Villaret et al. (2000) have also reported elevation of keratins 6 and 16 in HNSC tumor specimens. Paradoxically, Alevizos et al. (2001) using oligonucleotide array reported a low expression of keratins 4 and 15 in HNSC. Our results are also supported by previous investigations of head and neck and other mucosa-derived squamous carcinomas in which upregulation of basal and proliferation-induced keratins were found (Freedberg et al., 2001; Mischke, 1998) . The collective results suggest a potential diagnostic and biologic role for keratin expression in these tumors (Balm et al., 1996; Chu et al., 2001; Heyden et al., 1992; Ivanyi et al., 1990; Klijanienko et al., 1993; Mischke, 1998; Ogden et al., 1993) .
Proline-rich protein B1 (cornifin) showed consistently high expression levels in most of the conventional squamous carcinoma specimens but not in the variants. Cornifin is a 14 kDa protein member of the gene family involved in the formation of the crosslinked envelope of squamous cells, and it is typically expressed in the suprabasal layers (Abraham et al., 1996; Austin et al., 1996; Fujimoto et al., 1997; Harvat et al., 1997) . The protein manifests two forms, cornifinalpha and beta; only the latter is detected in oral, esophageal, and vaginal epithelia; the beta form does not appear in normal skin (Austin et al., 1996) . a Although the functional and biological significance of cornifin is presently unknown, the difference in expression of this gene in conventional and variant SCC suggests a potential diagnostic and biologic role in HNSC tumors.
Our analysis also showed a consistent overexpression of the S100C calcium-binding proteins. The functional and structural similarities between the S100 family genes, including S-100C (Calgizzarin), suggest an obligatory interaction for optimal gene expression of their transcriptional functions. These genes play a role in the differentiation, signal transduction, cell cycle and cytoskeletal membrane functions (Donato, 2001; Mischke, 1998) by regulating calcium levels during squamous differentiation. The elevation of calgizzarin in colon carcinoma parallels our findings and indicates a role in squamous tumorigenesis (Tanaka et al., 1995) . Another gene that was elevated in our study was the small nuclear RNA gene SM D1 which is important in the modification of ribosomal RNA and plays an important function in HNSC cell development Weinstein and Steitz, 1999) . Previous studies of lung and oral squamous carcinoma Sueoka et al., 1999) have demonstrated the overexpression of that gene in the majority of those tumors and its absence in normal tissues. hnRNP protein complex is a major component of mammalian nuclei and is involved in RNA splicing and mRNA transport to the cytoplasm. The temporal involvement of this gene in the development and progression of HNSC requires further analysis of premalignant and invasive lesions. Other elevated genes such as myosin and Mal-T are most likely due to host cell contamination.
Cluster analysis of all genes in our cases resulted in a distinct grouping of conventional SCC from their morphologic variants. All six conventional SCC cases showed overexpression of genes that represent different pathways including differentiation, cell proliferation, apoptosis, and invasion. The results from the GF211 membrane were similar to those from the GF200 membrane except for patient 5 whose tumor was classified in the SCC variant group. Interestingly, of the SCC variants, verrucous and sarcomatoid carcinomas showed a pattern of gene expression closer to each other than to papillary and basaloid carcinoma. In spite of the small number of b Figure 5 (a) Bi-directional hierarchical cluster analysis of gene expression of conventional (R02 -R07) HNSC and subtypes (R08 -R13) using GF211. (b) A more detailed look at two regions (1 and 2) of the GF211 gene expression profile Figure 6 Composite keratin 14 (a) and 5 (b) immunostaining in a conventional squamous carcinoma #R07 with high expression for both keratins by microarray analysis tumors analysed, our data suggest a potential use for this approach in classifying and differentiating HNSC tumors. We, however, found no evidence for an association between histologic grade of conventional SCC and gene profiling.
Our results also show a difference in gene expression pattern within the conventional SCCs, in which (GF200) all five tumors from the tongue were clustered together and were distinctly different from the only gingival tumor, suggesting an influence for tumor location. Our results also support previous comparative genomic hybridization and other molecular studies reporting variable molecular alterations within conventional squamous carcinoma of different anatomic sites (Bockmu¨hl et al., 2000) . Interestingly, a unique clustering and expression pattern was observed in case no 7 of this group (Figure 5a ). This case represented a tumor from a young female patient with advanced stage disease and high expression of matrix and proliferation associated genes such as MyC, EGFR and matrix metalloproteinasis. The gene profile and the clinicopathologic features of this case highlight the potential use of such analysis in evaluating the biological behavior of some individual tumors.
In summary, our study shows that certain genetic events are differentially altered in and between conventional and variant head and neck squamous carcinoma and these may have a potential diagnostic and biological implication in assessing these tumors. Because of the relatively small size and the short follow-up of patients, larger studies to validate and to determine the role of the differentially expressed genes identified are needed.
Materials and methods

Tissue samples
Twelve matched pairs of fresh-frozen normal mucosa and tumor specimens from resected primary HNSC from 1998 -2000 were harvested from the Department of Pathology at The University of Texas, M.D. Anderson Cancer Center and formed the material for this study. All patients underwent surgery with curative intent as their first treatment. None of the patients received prior chemotherapy or radiotherapy. We selected tumors from which a sufficient quantity of frozen material could be obtained. Normal mucosa was dissected from the farthest margin of resection after frozen-section verification. Invasive carcinoma components were carefully macrodissected from frozen blocks after frozen-section evaluation and mapping of tumor areas by a pathologist. The latter entailed mapping the non-tumorous areas on the H&E slide to guide carving these areas by surgical blade from frozen blocks. To verify the process, H&E stained sections were prepared from the remaining frozen block and reviewed to assess the completion of the dissection. Specimens with more than 90% neoplastic cells were used for analysis.
Gene filters
The gene filters used comprised of (Research Genetics) GF200 and 211 membranes of known and unknown genes which have previously been used in the CGAP project, to avoid some of the pitfalls of simultaneous array hybridization technique, and to increase the density of the genes analysed. The selection of both membranes was made to (1) increase the density of the gene pool to be analysed and (2) to test the expression of both known genes and unknown ESTs in these tumors.
RNA extraction
The RNA extraction was performed with TRIzol reagent according to manufacturer's protocol (TRIzol Reagent, Life Technologies) with some modifications. Tissue (1.5 mg) was ground and lysed in 2 ml of TRIzol reagent, and 0.4 ml of chloroform was added to the sample lysates. Samples were incubated at room temperature for 5 min and centrifuged at 12 000 g for 15 min at 48C. The RNA-containing phase was precipitated with a proportional volume of isopropanol (approximately 60% of added TRIzol volume), incubated for 10 min at room temperature, and centrifuged at 12 000 g for 10 min. The RNA pellet was washed with 2 ml of 75% ethanol, centrifuged at 7500 g for 5 min and dissolved in 40 ml diethyl pyrocarbonate-treated H 2 O. The RNA concentration was determined spectrophotometrically, and the RNA quality was examined electrophoretically using a 2% agarose gel.
Probe preparation
A double-stranded cDNA probe was generated from 4 mg total RNA labeled with 32 P-adCTP (NEN Life Product, Inc) of the Superscript cDNA System (Life Technologies) according to the manufacturer's instructions (Research Genetics) and was purified by a Bio-Spin 6 Chromatograph Column (Bio-Rad Laboratories). The purified probe was mixed with 10 mg poly(A) + and 1 mg human Cot-1 DNA, heat denatured at 988C for 8 min and preannealed at 428C for 1 h to mask repeats and reduce nonspecific hybridization signals. The probe was again denatured at 988C for 3 min prior to incubation in the hybridization chamber containing the gene filters.
Gene filter hybridization and wash
Nylon filter array GF200 or GF211 (Research Genetics) was placed in 5 ml MicroHyb hybridization buffer (Research Genetics), 2 mg polyT, and 2 mg predenatured Cot-1 DNA in a hybridization roller chamber (Hybaid, La Jolla, CA, USA) at 428C for 2 to 3 h in a hybridization oven. Denatured probe was added to the same buffer, and the hybridization reaction was kept at 428C overnight with gentle rotation (16 -18 h). The filter was washed twice for 20 min each at 558C in 30 ml of 26SSC/1% SDS followed by one wash for 15 min at room temperature in 100 ml of 0.56SSC/1% SDS on a horizontal shaker. The filter was immediately wrapped in 3M Whatman paper, wetted with deionized water, and exposed to a phosphor-imaging screen. The signal was detected by the Cyclone Phosphor Imaging System (Packard Bioscience Company). The data were analysed by Pathways Software (Research Genetics).
QT -RT -PCR mRNA analysis
Quantitative differences in RNA in normal and tumor specimens were examined using the ABI Prism 7700 sequence detection system from Applied Biosystems. The ABI Taqman one step RT -PCR master mix reagents kit was used for specimen analysis with the GAPDH as a control for normalization.
First, a standard curve was generated to determine that the concentrations of primers, probes and RNAs used were in the linear range for all three genes and amplified at the same efficiency. Each gene was amplified separately in duplicate using 0.2 ng of total RNA per 50 ml reaction. The reaction conditions were 30 min at 488C, 10 min at 958C, 40 cycles of 15 s at 958C, and 1 min at 608C.
Primer and probe sequences were selected using the ABI Primer Express program (Applied Biosystems). The sequences are as follows: Ker5-Fwd, 5'-TGAAGGCT-GATTTGAAGCAGAA; Ker5-Rev, 5'-CCAGGAGAGCC-CCATTCC; Ker5-Probe, 6 FAM-CTGGTCTCCCGTGCC-GCAGTTCTAT-TAMRA; SPRP-Fwd, 5'-CCATTTGCCT-TGCAATTAGCA; SPRP-Rev, 5'-CAGAGACTCAGAGT-GTGTAGGAAAGAA; and SPRP-Probe, 6-FAM-TGT-CTCCCCCAAAAAAGAATGTGCTATGAATAMRA. The GAPDH endogenous control primers and probes were a 20H mix available from Applied Biosystems (Foster City, CA, USA). Keratin 5 and SPRP primers were used at 900 pmol l
71
, and probes were used at 100 pmol l 71 . Fluorescence differences were collected by the 7700 AB1 thermal cycler during each 608C cycle. Semilogarithmic plots were constructed of delta fluorescence versus cycle number. For analysis, a threshold was set for the change in fluorescence at a point in the linear PCR-amplifications phase (Ct) (0.02 -0.04). The C t s for Ker 5 and SPRP were normalized to the C t s for GAPDH. The level of RNA for each gene in the tumor compared with the amount in the normal tissue was calculated using the equation X=2 Ct(N)7Ct(T) (X equals the fold overexpression in tumor versus normal tissue) (User Bulletin #2 ABI Prism 7700 Sequence Detection).
Experimental design
Duplicate experiments were performed on RNA extraction from matching specimens of each case. The magnitude of gene expression was initially quantified by both Pathways software and ArrayVision using different background correction methods; both platforms gave comparable results. We also observed minimal bleeding effects from high-signal spots on neighboring gene expression in our experiments. Consequently, only results based on Pathways analysis are presented.
A total of 96 experiments (12 patients62 tissues (normal, tumor)62 replicates62 membranes (GF200, GF211) were performed). Normal and tumor samples from the same patient were done using the same gene filter. In the majority of cases, up to four experiments (three strippings) were conducted on a single membrane. All images were examined visually and statistically to ensure that good quality and accurate quantification of the images had been achieved.
Immunohistochemistry
Paraffin-embedded tissue blocks from all tumors were available and a review of the corresponding hematoxylinand eosin stained sections was performed. Selected blocks were sectioned at 4 mm for immunostaining. [Monoclonal antibodies for S-100 protein (1 : 10 000, Biogenetics, San Ramon CA, USA) and keratin. CAM5.2, (1 : 200, BectonDickinson, San Jose CA, USA), keratin 5/6, 1 : 200 and keratin 19; 1 : 5 (Dako, 1 : 100, Carpentaria, CA, USA) were used for detection of these markers]. Immunohistochemistry was performed using the avidin-biotin complex (ABC) method of Hse et al. (1981) .
Statistical considerations
Our main objectives were as follows: (1) to identify differentially expressed genes in tumor and normal tissue in six patients with conventional SCC and in six patients with variant SCC; and (2) to perform molecular classification using the bidirectional cluster analysis algorithm. A total of 5453 genes were spotted on GF200 with 192 control-positive spots containing the total genomic DNA (tgDNA) and 192 housekeeping genes (HKG). For GF211, a total of 4324 genes with 192 control-positive genes were spotted. A logarithm-10 based transformation was applied to all raw intensity data. The hexbin scatter plot and scatter plot matrix using the S-PLUS (S-PLUS 200 Guide, 2000) were used to display the log intensity of gene expression of tumor versus normal tissue for each matched-pair experiment. Brushing technique was applied to highlight selected genes such as tgDNA or HKG. From the scatter plots, we found that tgDNA clustered by itself with moderate intensity (indicating adequate hybridization) in both normal and tumor samples. Because tgDNA is used for the purpose of providing positive controls and contains both human and nonhuman genes, we removed the tgDNA genes from further analysis. There were a total of 8055 unique genes included in the analysis.
Normalization of the gene-expression intensity in the normal and tumor tissues for each pair was carried out by plotting the logarithm-transformed intensity in tumor verses normal tissue; fitting a nonparametric regression line using the loess (locally weighted regression scatter plot smoothing) method; and assuming that most genes do not vary greatly in their expression levels (the goal was to move the loess line to superimpose with the 458 line where x-and y-coordinates are the same). This was achieved by projecting each point to the 458 line along the x-axis and the y-axis and then taking the average of the two. The differential expression was computed by forming the difference between normalized, log-transformed expressions in tumor and normal tissue and then taking the arithmetic average in replicated experiments.
To identify the expressed genes between normal and tumor tissues for each of the two subtypes of SCC (conventional versus variant) and two nylon membranes (GF200 and GF211), we took the following two steps:
Step A: We generated a list of differentially expressed genes by the following five methods: (1) simple average method: Take the average of differential gene expression in all six patients and select genes in which the mean is at least twofold difference, (2) simple ranking method: Rank the differential expression of genes in each patient, compute the averaged rank and select genes in the top one percentile, (3) common twofold method: Select genes with a twofold or more difference in at least three out of six patients, (4) common 1% method: Select genes in the top 1 percentile in at least three out of six patients, (5) t-test method: Apply the t-test with five degrees of freedom and select genes with P50.01. Note that methods 1 and 2 select genes based on the average expression. Methods 3 and 4 select genes as long as they are differentially expressed in 50% of the patients. Method 5 takes the variability among patients into consideration by dividing the mean average by its standard error. The Q-Q plots show that the statistics follow t-distribution with five degrees of freedom.
Step B: The final differentially expressed genes chosen for the list are those that make the list in Step A by at least three out of five methods.
Hierarchical clustering analysis was performed on both GF200 and GF211 differentially expressed genes of the 12 cases using the software developed by Eisen et al. (1998) . Bidirectional clustering was performed to cluster both patients and genes. The Pearson correlation coefficient was used as the similarity metric, and the average-linkage method was applied to assemble all elements into a clustering tree.
